Frequency_NN of_IN Disinfectant_NP Resistance_NP Genes_NPS and_CC Genetic_NP Linkage_NP with_IN beta-Lactamase_NP Transposon_NP Tn552_NP among_IN Clinical_NP Staphylococci_NP A_DT total_NN of_IN 61_CD strains_NNS of_IN Staphylococcus_NP aureus_NN and_CC 177_CD coagulase-negative_JJ staphylococcal_JJ strains_NNS were_VBD isolated_VBN from_IN the_DT blood_NN of_IN patients_NNS with_IN bloodstream_NN infections_NNS and_CC from_IN the_DT skin_NN of_IN both_DT children_NNS under_IN cancer_NN treatment_NN and_CC human_JJ immunodeficiency_NN virus-positive_JJ patients_NNS ._SENT The_DT MIC_JJ analyses_NNS revealed_VBD that_IN 118_CD isolates_NNS (_( 50_CD %_NN )_) were_VBD resistant_JJ to_TO quaternary_JJ ammonium_NN compound-based_JJ disinfectant_NN benzalkonium_NN chloride_NN (_( BC_NP )_) ._SENT The_DT frequencies_NNS of_IN resistance_NN to_TO a_DT range_NN of_IN antibiotics_NNS were_VBD significantly_RB higher_JJR among_IN BC-resistant_JJ staphylococci_NNS than_IN among_IN BC-sensitive_JJ staphylococci_NNS ._SENT Of_IN 78_CD BC-resistant_JJ staphylococcal_JJ isolates_NNS ,_, plasmid_NP DNA_NP from_IN 65_CD (_( 83_CD %_NN )_) ,_, 2_CD (_( 3_CD %_NN )_) ,_, 43_CD (_( 55_CD %_NN )_) ,_, and_CC 15_CD (_( 19_CD %_NN )_) isolates_VBZ hybridized_VBN to_TO qacA_NN or_CC -B_NN (_( qacA/B_NN )_) ,_, qacC_NP ,_, blaZ_NP ,_, and_CC tetK_NN probes_NNS ,_, respectively_RB ._SENT The_DT qacA/B_NN and_CC blaZ_NN probes_NNS hybridized_VBD to_TO the_DT same_JJ plasmid_NN in_IN 19_CD (_( 24_CD %_NN )_) staphylococcal_JJ strains_NNS ._SENT The_DT plasmids_NNS harboring_VBG both_DT qacA/B_NN and_CC blaZ_NN genes_NNS varied_VBN from_IN approximately_RB 20_CD to_TO 40_CD kb_NN ._SENT The_DT Staphylococcus_NP epidermidis_NP Fol62_NP isolate_NN ,_, harboring_VBG multiresistance_NN plasmid_NN pMS62_NN ,_, contained_VBD qacA/B_NN and_CC blaZ_NN together_RB with_IN tetK_NN ._SENT Molecular_JJ and_CC genetic_JJ studies_NNS indicated_VBD different_JJ structural_JJ arrangements_NNS of_IN blaZ_NN and_CC qacA/B_NN ,_, including_VBG variable_JJ intergenic_JJ distances_NNS and_CC transcriptional_JJ directions_NNS of_IN the_DT two_CD genes_NNS on_IN the_DT same_JJ plasmid_NN within_IN the_DT strains_NNS ._SENT The_DT different_JJ organizations_NNS may_MD be_VB due_JJ to_TO the_DT presence_NN of_IN various_JJ genetic_JJ elements_NNS involved_VBN in_IN cointegration_NN ,_, recombination_NN ,_, and_CC rearrangements_NNS ._SENT These_DT results_NNS indicate_VBP that_IN qac_JJ resistance_NN genes_NNS are_VBP common_JJ and_CC that_DT linkage_NN between_IN resistance_NN to_TO disinfectants_NNS and_CC penicillin_NN resistance_NN occurs_VBZ frequently_RB in_IN clinical_JJ isolates_NNS in_IN Norway_NP ._SENT Moreover_RB ,_, the_DT higher_JJR frequency_NN of_IN antibiotic_JJ resistance_NN among_IN BC-resistant_JJ strains_NNS indicates_VBZ that_IN the_DT presence_NN of_IN either_DT resistance_NN determinant_NN selects_VBZ for_IN the_DT other_JJ during_IN antimicrobial_JJ therapy_NN and_CC disinfection_NN in_IN hospitals_NNS ._SENT Staphylococci_NNS ,_, including_VBG Staphylococcus_NP aureus_NN and_CC the_DT coagulase-negative_JJ staphylococci_NNS (_( CNS_NP )_) ,_, and_CC enterococci_NNS account_VBP for_IN approximately_RB one-third_JJ of_IN all_DT bloodstream_NN infections_NNS and_CC up_RB to_TO 50_CD %_NN of_IN nosocomial_JJ bloodstream_NN infections_NNS ._SENT In_IN the_DT past_NN ,_, CNS_NP were_VBD considered_VBN to_TO be_VB very_RB rarely_RB involved_VBN in_IN disease_NN ,_, but_CC since_IN the_DT 1980s_NNS there_EX has_VBZ been_VBN increasing_VBG evidence_NN that_IN CNS_NP can_MD act_VB as_IN opportunistic_JJ pathogens_NNS and_CC can_MD be_VB a_DT frequent_JJ and_CC important_JJ cause_NN of_IN disease_NN ._SENT In_IN recent_JJ years_NNS there_EX has_VBZ been_VBN a_DT dramatic_JJ increase_NN in_IN the_DT prevalence_NN of_IN multiple-drug-resistant_JJ strains_NNS ._SENT Worldwide_NP emergence_NN of_IN antimicrobial_JJ resistance_NN in_IN staphylococci_NNS is_VBZ probably_RB a_DT serious_JJ and_CC increasing_JJ problem_NN ,_, especially_RB in_IN hospitals_NNS ._SENT Disinfectants_NNS based_VBN on_IN quaternary_JJ ammonium_NN compounds_NNS (_( QACs_NP )_) ,_, e.g._FW ,_, benzalkonium_NN chloride_NN (_( BC_NP )_) ,_, cetylpyridinium_NN chloride_NN ,_, cetrimide_NN ,_, proceine_NN ,_, and_CC detizor_NN ,_, are_VBP frequently_RB used_VBN in_IN hospitals_NNS to_TO disinfect_VB and_CC to_TO prevent_VB the_DT spread_NN of_IN pathogens_NNS ._SENT It_PP has_VBZ been_VBN suggested_VBN that_IN the_DT widespread_JJ use_NN of_IN QACs_NP may_MD impose_VB a_DT selective_JJ pressure_NN and_CC contribute_VB to_TO the_DT emergence_NN of_IN disinfectant-resistant_JJ microorganisms_NNS in_IN these_DT environments_NNS ._SENT Known_VBN qac_JJ resistance_NN genes_NNS reported_VBN in_IN clinical_JJ staphylococci_NNS ,_, qacA_NP ,_, qacB_NN ,_, and_CC qacC/smr_NN ,_, are_VBP generally_RB plasmid_NN borne_VBN and_CC are_VBP widely_RB distributed_VBN in_IN the_DT environment_NN ._SENT Large_JJ consumption_NN of_IN antibiotics_NNS by_IN both_DT humans_NNS and_CC animals_NNS has_VBZ resulted_VBN in_IN the_DT development_NN and_CC spread_NN of_IN a_DT large_JJ number_NN of_IN antibiotic_JJ resistance_NN determinants_NNS among_IN bacterial_JJ populations_NNS ,_, thus_RB creating_VBG critical_JJ public_JJ health_NN problems_NNS ._SENT Concerns_NNS have_VBP arisen_VBN regarding_VBG the_DT potential_JJ emergence_NN of_IN cross-resistance_NN and_CC coresistance_NN between_IN widely_RB used_VBN disinfectants_NNS and_CC antibiotics_NNS ._SENT Resistance_NN genes_NNS on_IN transferable_JJ genetic_JJ elements_NNS such_JJ as_IN plasmids_NNS and_CC transposons_NNS may_MD lead_VB to_TO the_DT epidemic_JJ spread_NN of_IN resistance_NN between_IN species_NNS ._SENT On_IN some_DT of_IN the_DT published_VBN plasmids_NNS (_( pST6_NP ,_, pSK4_NN ,_, and_CC pSK41_JJ )_) and_CC transposons_NNS (_( Tn552_NP and_CC Tn4002_NP )_) ,_, qac_JJ resistance_NN determinants_NNS are_VBP located_VBN together_RB with_IN antibiotic_JJ resistance_NN genes_NNS encoding_VBG resistance_NN to_TO gentamicin_NN (_( GEN_NP )_) ,_, trimethoprim_NP (_( TMP_NP )_) ,_, penicillin_NN ,_, kanamycin_NN (_( KAN_NP )_) ,_, and_CC tobramycin_NN ._SENT Staphylococcal_JJ beta-lactamase_NN structural_JJ gene_NN blaZ_NN and_CC two_CD closely_RB linked_VBN genes_NNS ,_, blaI_NNS and_CC blaR_NN ,_, that_WDT control_VBP its_PP$ expression_NN have_VBP been_VBN identified_VBN on_IN several_JJ transposons_NNS ,_, e.g._FW ,_, Tn552_NP ,_, and_CC large_JJ plasmids_NNS ,_, e.g._FW ,_, pST6_NN ,_, as_RB well_RB as_IN on_IN the_DT chromosome_NN ._SENT Staphylococcal_JJ beta-lactamase_NN transposon_NP Tn552_NP is_VBZ closely_RB related_VBN to_TO staphylococcal_JJ transposons_NNS Tn4002_NP ,_, Tn3852_NP ,_, and_CC Tn4201_NP and_CC to_TO Tn4201-like_JJ elements_NNS ._SENT Staphylococcal_JJ transposons_NNS contains_VBZ terminal_JJ inverted_JJ repeats_NNS (_( TIR_NP )_) at_IN their_PP$ ends_NNS that_WDT serve_VBP as_IN recognition_NN sequences_NNS for_IN transposase_NN in_IN their_PP$ role_NN of_IN fusing_VBG the_DT ends_NNS of_IN the_DT transposon_NN with_IN the_DT recipient_JJ DNA_NN ._SENT The_DT three_CD genes_NNS (_( blaI_NP ,_, blaR_NN ,_, and_CC blaZ_NN )_) involved_VBN in_IN beta-lactamase_NN production_NN constitute_VBP the_DT right_JJ half_NN of_IN transposon_NP Tn552_NP (_( Tn552-like_JJ bla_NN gene_NN module_NN )_) ._SENT The_DT left_VBN half_NN of_IN Tn552_NP consists_VBZ of_IN genes_NNS p271_JJ ,_, encoding_VBG a_DT potential_JJ ATP-binding_NP protein_NN ,_, p480_NN ,_, encoding_VBG a_DT transposase_NN ,_, binL_NN ,_, encoding_VBG a_DT resolvase_NN ,_, and_CC a_DT resolution_NN site_NN ,_, resL_NN ._SENT Partial_JJ and_CC complete_JJ genetic_JJ structural_JJ arrangements_NNS of_IN Tn552_NP in_IN staphylococci_NNS from_IN different_JJ geographic_JJ locations_NNS have_VBP been_VBN described_VBN ._SENT Some_DT staphylococci_NNS harbor_VBP only_RB the_DT right_NN or_CC left_JJ half_NN of_IN Tn552_NP ._SENT Staphylococcal_JJ insertion_NN sequence_NN IS257_JJ ,_, associated_VBN with_IN Tn552_NP and_CC IS256_NP ,_, has_VBZ been_VBN shown_VBN to_TO be_VB an_DT active_JJ mobile_JJ genetic_JJ element_NN ._SENT There_EX is_VBZ limited_JJ knowledge_NN concerning_VBG the_DT frequency_NN of_IN QAC_NP resistance_NN and_CC the_DT genetic_JJ linkage_NN between_IN qac-mediated_JJ resistance_NN and_CC antibiotic_JJ resistance_NN genes_NNS ._SENT In_IN this_DT study_NN ,_, we_PP investigated_VBD the_DT presence_NN and_CC genetic_JJ linkage_NN of_IN known_VBN qac_NN resistance_NN determinants_NNS and_CC antibiotic_JJ resistance_NN genes_NNS ,_, along_RB with_IN genetic_JJ mobile_JJ elements_NNS ,_, in_IN staphylococci_NNS isolated_VBN from_IN clinical_JJ environments_NNS ._SENT Bacterial_JJ strains_NNS ,_, culture_NN media_NNS ,_, and_CC growth_NN conditions_NNS ._SENT |_SYM A_DT total_NN of_IN 61_CD isolates_NNS of_IN S._NP aureus_NN and_CC 177_CD CNS_NP isolates_NNS were_VBD included_VBN in_IN this_DT study_NN ._SENT The_DT staphylococci_NNS were_VBD isolated_VBN from_IN patients_NNS in_IN four_CD different_JJ hospitals_NNS ._SENT S._NP aureus_NN (_( n_NN =_SYM 61_CD )_) and_CC CNS_NP (_( n_NN =_SYM 60_CD )_) were_VBD isolated_VBN from_IN patients_NNS with_IN bloodstream_NN infections_NNS at_IN two_CD hospitals_NNS (_( Molde_NP County_NP Hospital_NP and_CC Norwegian_NP Radium_NP Hospital_NP )_) during_IN 1991_CD to_TO 1992_CD and_CC 1995_CD to_TO 1996_CD ._SENT The_DT CNS_NP isolates_VBZ (_( n_NN =_SYM 56_CD )_) from_IN the_DT skin_NN of_IN human_JJ immunodeficiency_NN virus_NN (HIV)-positive_JJ patients_NNS were_VBD from_IN Ulleval_NP Hospital_NP ,_, while_IN the_DT remaining_VBG 61_CD CNS_NP isolates_NNS were_VBD obtained_VBN at_IN two_CD hospitals_NNS (_( Ulleval_NP Hospital_NP and_CC Rikshospitalet_NP University_NP Hospital_NP )_) from_IN the_DT skin_NN of_IN children_NNS under_IN cancer_NN treatment_NN receiving_VBG cytostatica_NN and_CC undergoing_VBG multiple-antibiotic_JJ cures_NNS ._SENT In_IN all_DT cases_NNS ,_, repeat_NN isolates_NNS from_IN the_DT same_JJ patient_NN were_VBD excluded_VBN ._SENT This_DT strain_NN collection_NN represents_VBZ staphylococci_NNS from_IN different_JJ types_NNS of_IN hospitals_NNS and_CC patients_NNS subject_JJ to_TO various_JJ degrees_NNS of_IN antimicrobial_JJ treatment_NN ._SENT Reference_NN strains_NNS were_VBD Staphylococcus_NP haemolyticus_NP NVH97A_NP (_( resistant_JJ to_TO BC_NP and_CC penicillin_NN )_) and_CC S._NP aureus_NN RN4220_NP ,_, S._NP haemolyticus_NP DSM20623_NP ,_, and_CC S._NP aureus_NN ATCC_NP 25923_CD (_( sensitive_JJ to_TO BC_NP and_CC penicillin_NN )_) ._SENT All_DT staphylococcus_NN strains_NNS were_VBD cultured_VBN in_IN Mueller-Hinton_NP (_( MH_NP )_) broth_NN or_CC on_IN MH_NP agar_NN plates_NNS (_( Difco_NP Laboratories_NP ,_, Detroit_NP ,_, Mich._NP )_) at_IN 37C_JJ ._SENT Isolates_NNS were_VBD preserved_VBN in_IN MH_NP broth_NN with_IN 15_CD %_NN glycerol_NN at_IN -80C_NN ._SENT Antimicrobial_JJ agents_NNS ._SENT |_SYM BC_NP was_VBD from_IN the_DT Norwegian_JJ Medical_NP Depot_NP (_( Oslo_NP ,_, Norway_NP )_) ._SENT Ampicillin_NP (_( AMP_NP )_) ,_, penicillin_NN G_NP (_( PEN_NP )_) ,_, methicillin_NP (_( MET_NP )_) ,_, tetracycline_NN (_( TET_NP )_) ,_, erythromycin_NN (_( ERY_NP )_) ,_, KAN_NP ,_, GEN_NP ,_, chloramphenicol_NN ,_, TMP_NP ,_, and_CC ethidium_NN bromide_NN (_( EBR_NP )_) were_VBD purchased_VBN from_IN Sigma_NP Chemical_NP Co._NP (_( St._NP Louis_NP ,_, Mo._NP )_) ,_, and_CC chlorhexidine_NP (_( CHX_NP )_) was_VBD from_IN Nycomed_NP (_( Oslo_NP ,_, Norway_NP )_) ._SENT Amphoteric_JJ disinfectant_NN Tego_NP 103G_NP was_VBD purchased_VBN from_IN Otto_NP Olsen_NP AS_NP (_( Lillestrom_NP ,_, Norway_NP )_) ._SENT Neo-Sensitabs_NP disks_NNS (_( Rosco_NP ,_, Medkjemi_NP A/S_NP ,_, Taastrup_NP ,_, Denmark_NP )_) containing_VBG antimicrobial_JJ agents_NNS were_VBD used_VBN for_IN susceptibility_NN testing_NN ._SENT Susceptibility_NN tests_NNS ._SENT |_SYM MICs_NP of_IN antimicrobial_JJ agents_NNS and_CC dyes_NNS were_VBD determined_VBN by_IN the_DT microdilution_NN method_NN and_CC by_IN E_NN test_NN using_VBG MH_NP medium_NN ._SENT The_DT lowest_JJS concentration_NN of_IN an_DT antimicrobial_JJ agent_NN and_CC dye_NN that_WDT totally_RB inhibited_VBD bacterial_JJ growth_NN after_IN 24_CD h_NN of_IN incubation_NN at_IN 37C_NP was_VBD considered_VBN the_DT MIC_NN ._SENT Antibiotic_JJ susceptibility_NN patterns_NNS were_VBD also_RB examined_VBN by_IN the_DT disk_NN diffusion_NN method_NN (_( Neo-Sensitabs_NP user_NN 's_POS guide_NN ,_, Rosco_NP )_) ._SENT The_DT diameters_NNS of_IN the_DT inhibition_NN zones_NNS around_IN antimicrobial_JJ disks_NNS were_VBD measured_VBN in_IN millimeters_NNS after_IN 2_CD days_NNS of_IN incubation_NN at_IN 37C_JJ and_CC compared_VBN to_TO standard_JJ MIC_JJ breakpoints_NNS recommended_VBN by_IN "_`` Susceptibility_NN testing_NN standardization_NN groups_NNS "_'' (_( Neo-Sensitabs_NP user_NN 's_POS guide_NN ,_, Rosco_NP )_) ._SENT The_DT results_NNS were_VBD interpreted_VBN as_IN recommended_VBN by_IN the_DT Norwegian_JJ AFA_NP Group_NP (_( Neo-Sensitabs_NP user_NN 's_POS guide_NN )_) ._SENT Susceptibility_NN tests_NNS for_IN the_DT isolates_NNS resistant_JJ to_TO BC_NP and_CC PEN_NP were_VBD repeated_VBN two_CD times_NNS on_IN different_JJ days_NNS ._SENT MIC_JJ testing_NN with_IN disinfectants_NNS BC_NP and_CC Tego_NP 103G_NP was_VBD carried_VBN out_RP by_IN using_VBG 1-mug/ml_JJ intervals_NNS from_IN 0_CD to_TO 10_CD mug/ml_NN ._SENT For_IN CHX_NP the_DT interval_NN was_VBD 0.5_CD mug/ml_NN from_IN 0_CD to_TO 4_CD mug/ml_NN ._SENT MIC_JJ tests_NNS with_IN PEN_NP ,_, AMP_NP ,_, and_CC EBR_NP were_VBD performed_VBN by_IN using_VBG twofold_JJ dilutions_NNS starting_VBG from_IN 320_CD mug/ml_NN ._SENT DNA_NP isolation_NN and_CC analysis_NN ._SENT |_SYM Cells_NP were_VBD lysed_VBN with_IN lysostaphin_NP (_( Sigma-Aldrich_NP ,_, St._NP Louis_NP ,_, Mo._NP )_) at_IN a_DT concentration_NN of_IN 40_CD mug/ml_NN and_CC incubated_VBN at_IN 37C_JJ for_IN 30_CD min_NN ._SENT Total_NP DNA_NP and_CC plasmid_NP DNA_NP were_VBD isolated_VBN by_IN Easy-DNA_NP (_( Invitrogen_NP ,_, Carlsbad_NP ,_, Calif._NP )_) and_CC QIAprep_NP spin_VB (_( Qiagen_NP GmbH_NP ,_, Hilden_NP ,_, Germany_NP )_) kits_NNS ,_, respectively_RB ._SENT After_IN agarose_JJ gel_NN electrophoresis_NN ,_, the_DT DNA_NN was_VBD stained_VBN with_IN EBR_NP and_CC visualized_VBN under_IN UV_NP light_NN ._SENT Plasmid_NP curing_VBG ._SENT |_SYM Strains_NP were_VBD grown_VBN in_IN increasing_VBG sublethal_JJ concentrations_NNS of_IN novobiocin_NN in_IN MH_NP broth_NN as_IN described_VBN by_IN Heir_NP et_FW al._FW ._SENT Southern_JJ blotting_VBG and_CC hybridization_NN ._SENT |_SYM Plasmid_NP DNA_NP and_CC total_JJ DNA_NN were_VBD transferred_VBN from_IN agarose_JJ gel_NN to_TO a_DT Hybond-N+_NP nylon_NN membrane_NN (_( Amersham_NP Pharmacia_NP Biotech_NP ,_, Buckinghamshire_NP ,_, United_NP Kingdom_NP )_) along_IN with_IN positive_JJ and_CC negative_JJ control_NN DNA_NN by_IN vacuum_NN blotting_VBG ,_, according_VBG to_TO the_DT manufacturer_NN 's_POS instructions_NNS (_( Pharmacia_NP ,_, Uppsala_NP ,_, Sweden_NP )_) ._SENT PCR_NP products_NNS (_( see_VB below_IN )_) specific_JJ for_IN genes_NNS qacA_NN and_CC qacB_NN (_( common_JJ probe_NN )_) ,_, qacC_NP ,_, qacG_NN ,_, qacH_NP ,_, blaZ_NP ,_, blaR_NN ,_, blaI_NP ,_, ermC_NP ,_, cat_NN ,_, tetK_NN ,_, aacA-aphD_NNS ,_, and_CC dfrA_NN and_CC insertion_NN sequences_NNS IS257_JJ and_CC IS256_NP were_VBD used_VBN as_IN probes_NNS ._SENT The_DT PCR_NP products_NNS were_VBD purified_VBN with_IN a_DT Qiagen_NP PCR_NP product_NN purification_NN kit_NN and_CC sequenced_JJ on_IN an_DT ABI_NP PRISM_NN 377_CD (_( Applied_NP Biosystems_NP ,_, Perkin-Elmer_NP Cetus_NP Corp._NP ,_, Norwalk_NP ,_, Conn._NP )_) before_IN being_VBG used_VBN as_IN probes_NNS ._SENT The_DT labeling_VBG of_IN probes_NNS and_CC hybridization_NN were_VBD done_VBN with_IN an_DT AlkPhos_JJ direct_JJ gene_NN image_NN kit_NN in_IN accordance_NN with_IN the_DT manufacturer_NN 's_POS instructions_NNS (_( Amersham_NP Pharmacia_NP Biotech_NP )_) ._SENT Membrane_NN stripping_VBG was_VBD done_VBN as_IN recommended_VBN by_IN the_DT manufacturer_NN ._SENT PCR_NP amplification_NN ._SENT |_SYM The_DT primers_NNS used_VBN for_IN PCR_NP amplifications_NNS were_VBD designed_VBN from_IN previously_RB known_VBN sequences_NNS ._SENT All_PDT the_DT designed_VBN primers_NNS were_VBD first_RB tested_VBN for_IN their_PP$ specificity_NN on_IN known_VBN positive_JJ and_CC negative_JJ control_NN strains_NNS ._SENT To_TO obtain_VB probes_NNS for_IN DNA_NN hybridization_NN ,_, standard_JJ PCR_NP was_VBD carried_VBN out_RP for_IN qacA_NN or_CC -B_NN (_( qacA/B_NN )_) ,_, qacC_NP ,_, qacG_NN ,_, qacH_NP ,_, blaZ_NP ,_, blaR_NN ,_, blaI_NP ,_, ermC_NP ,_, cat_NN ,_, tetK_NN ,_, aacA-aphD_NNS ,_, dfrA_NP ,_, IS257_JJ ,_, and_CC IS256_NP ._SENT Each_DT PCR_NP mixture_NN contained_VBD 50_CD ng_NNS of_IN plasmid_NP DNA_NP ,_, 2_CD muM_NN (_( each_DT )_) primer_NN ,_, 200_CD muM_NN (_( each_DT )_) deoxynucleoside_NN triphosphate_NN ,_, 2.5_CD muM_NN MgCl2_NP ,_, 1x_NP reaction_NN buffer_NN (_( Promega_NP Corp._NP ,_, Madison_NP ,_, Wis._NP )_) ,_, and_CC 2.5_CD U_NN of_IN Taq_NP DNA_NP polymerase_NN (_( Promega_NP Corp._NP )_) in_IN a_DT total_JJ volume_NN of_IN 50_CD mul_NN ._SENT Reaction_NN mixtures_NNS were_VBD subjected_VBN to_TO 30_CD cycles_NNS of_IN amplification_NN ._SENT The_DT conditions_NNS for_IN each_DT cycle_NN were_VBD denaturation_NN for_IN 1_CD min_NN at_IN 95C_NN ,_, annealing_VBG for_IN 1_CD min_NN at_IN between_IN 50_CD and_CC 55C_NP depending_VBG on_IN the_DT primer_NN set_NN ,_, and_CC primer_JJR extension_NN for_IN 2_CD min_NN at_IN 72C_NP ._SENT Finally_RB ,_, reaction_NN mixtures_NNS were_VBD incubated_VBN at_IN 72C_NP for_IN 10_CD min_NN ._SENT The_DT PCR_NP products_NNS were_VBD separated_VBN by_IN electrophoresis_NN in_IN a_DT 1_CD %_NN agarose_NN gel_NN ,_, stained_VBN with_IN EBR_NP ,_, and_CC visualized_VBD under_IN UV_NP light_NN ._SENT XL-PCR_NP ._SENT |_SYM The_DT primers_NNS used_VBN for_IN extralong_JJ PCR_NP (_( XL-PCR_NP )_) amplification_NN are_VBP included_VBN in_IN Table_NP ._SENT The_DT XL-PCR_NP was_VBD carried_VBN out_RP with_IN a_DT GeneAmp_NP XL-PCR_NP kit_NN (_( Applied_NP Biosystems_NP )_) in_IN accordance_NN with_IN the_DT manufacturer_NN 's_POS instructions_NNS with_IN slight_JJ modifications_NNS ._SENT The_DT GeneAmp_NP XL-PCR_NP kit_NN (_( Perkin-Elmer_NP Cetus_NP Corp._NP )_) was_VBD used_VBN for_IN amplification_NN of_IN the_DT DNA_NN regions_NNS between_IN the_DT beta-lactamase_NN genes_NNS and_CC disinfectant_NN resistance_NN gene_NN qacA/B_NN ._SENT The_DT primer_NN combinations_NNS used_VBN were_VBD qac_JJ IV_NP and_CC blaI_NP R2_NP and_CC qac_NP IV_NP and_CC blaZ_NP 2F_NP (_( see_NN Fig._NN ;_: Table_NP )_) ._SENT The_DT DNA_NP region_NN between_IN qacA/B_NN and_CC staphylococcal_JJ insertion_NN element_NN IS257_JJ was_VBD amplified_VBN by_IN using_VBG primers_NNS qac_JJ IV_NP and_CC IS257_JJ F_NN (_( see_VB Fig._NN )_) ._SENT Each_DT PCR_NP mixture_NN contained_VBD 10_CD ng_NNS of_IN plasmid_NP DNA_NP ,_, 2_CD muM_NN (_( each_DT )_) PCR_NP primer_NN ,_, 200_CD muM_NN (_( each_DT )_) deoxynucleoside_NN triphosphate_NN ,_, 1_CD mM_NP MgCl2_NP ,_, and_CC 1.5_CD U_NN of_IN rTh_JJ DNA_NN polymerase-XL_NN in_IN a_DT total_JJ volume_NN of_IN 50_CD mul_NN ._SENT The_DT cycle_NN conditions_NNS were_VBD preliminary_JJ denaturation_NN for_IN 2_CD min_NN at_IN 93C_NN ,_, followed_VBN by_IN 25_CD cycles_NNS of_IN denaturation_NN at_IN 93C_NN for_IN 1_CD min_NN ,_, annealing_VBG for_IN 45_CD s_NNS at_IN between_IN 47_CD and_CC 50C_NP depending_VBG on_IN the_DT primer_NN set_NN ,_, and_CC primer_JJR extension_NN for_IN 7_CD min_NN at_IN 68C_JJ ._SENT Finally_RB ,_, reaction_NN mixtures_NNS were_VBD incubated_VBN at_IN 68C_JJ for_IN 5_CD to_TO 12_CD min_NN depending_VBG on_IN the_DT primer_NN set_VBD ._SENT The_DT PCR_NP products_NNS were_VBD examined_VBN by_IN electrophoresis_NN in_IN a_DT 0.7_CD or_CC 1.0_CD %_NN agarose_NN gel_NN ,_, stained_VBN with_IN EBR_NP ,_, and_CC visualized_VBD under_IN UV_NP light_NN ._SENT DNA_NP sequencing_NP ._SENT |_SYM The_DT nucleotide_NN sequences_NNS of_IN PCR_NP products_NNS and_CC XL-PCR_NP products_NNS were_VBD determined_VBN by_IN using_VBG an_DT ABI_NP PRISM_NP BigDye_NP terminator_NN cycle_NN sequencing_VBG ready_JJ reaction_NN kit_NN (_( Applied_NP Biosystems_NP )_) with_IN synthetic_JJ oligonucleotide_NN primers_NNS on_IN an_DT ABI_NP PRISM_NN 377_CD automatic_JJ sequencer_NN (_( Applied_NP Biosystems_NP )_) as_RB recommended_VBD by_IN the_DT manufacturer_NN ._SENT Before_IN application_NN on_IN the_DT sequencer_NN ,_, the_DT extension_NN products_NNS were_VBD purified_VBN as_IN described_VBN by_IN the_DT manufacturer_NN ._SENT Unknown_JJ flanking_VBG DNA_NN fragments_NNS were_VBD isolated_VBN by_IN a_DT two-step_JJ PCR_NP method_NN (_( A._NP B._NP Sorensen_NP ,_, M._NP Duch_NP ,_, and_CC F._NP S._NP Pedersen_NP ,_, Dynalogue_NP customer_NN report_NN 3:2-3_CD ,_, 1999_CD )_) ._SENT The_DT unknown_JJ DNA_NN flanking_VBG regions_NNS were_VBD amplified_VBN with_IN primers_NNS coupled_VBN to_TO biotin_NN at_IN the_DT 5_CD '_POS end_NN and_CC degenerate_JJ flanking_VBG primers_NNS in_IN first-step_JJ PCR_NP ._SENT The_DT PCR_NP products_NNS were_VBD bound_VBN to_TO Dynabead-streptavidin_NP beads_NNS and_CC purified_VBN with_IN a_DT Dynabeads_NP kilobaseBINDER_NN kit_NN (_( Dynal_NP ,_, Oslo_NP ,_, Norway_NP )_) ._SENT The_DT purified_VBN PCR_NP products_NNS from_IN the_DT first-step_NN PCR_NP were_VBD then_RB used_VBN as_IN templates_NNS for_IN nested_VBN PCR_NP followed_VBN by_IN DNA_NP sequencing_NP ._SENT Nucleotide_NN sequences_NNS were_VBD analyzed_VBN by_IN using_VBG the_DT BLAST_NP website_NN program_NN (_( National_NP Center_NP for_IN Biotechnology_NP Information_NP ,_, National_NP Institutes_NPS of_IN Health_NP )_) ,_, the_DT Sequencher_NP ,_, version_NN 3.0_CD ,_, software_NN package_NN (_( Gene_NP Codes_NP Corporation_NP ,_, Ann_NP Arbor_NP ,_, Mich._NP )_) ,_, and_CC the_DT GCG_NP sequence_NN analysis_NN software_NN package_NN ,_, version_NN 8_CD (_( Genetics_NP Computer_NP Group_NP ,_, Madison_NP ,_, Wis._NP )_) ._SENT Nucleotide_NN sequence_NN accession_NN numbers_NNS ._SENT |_SYM The_DT nucleotide_NN sequences_NNS reported_VBD in_IN this_DT study_NN have_VBP been_VBN assigned_VBN accession_NN no_RB ._SENT ,_, ,_, and_CC in_IN the_DT GenBank_NP database_NN ._SENT FIG._NN 2_CD ._SENT |_SYM Genetic_JJ organization_NN of_IN qac_NN and_CC beta-lactam_NN resistance_NN genes_NNS in_IN staphylococcal_JJ isolates_NNS Fol24_NP ,_, Fol33_NP ,_, Fol62_NP ,_, Fol89_NP ,_, Fol90_NP ,_, and_CC Fol100_NP ._SENT Genetic_JJ organization_NN of_IN qac_NN and_CC beta-lactam_NN resistance_NN genes_NNS in_IN staphylococcal_JJ isolates_NNS Fol24_NP ,_, Fol33_NP ,_, Fol62_NP ,_, Fol89_NP ,_, Fol90_NP ,_, and_CC Fol100_NP ._SENT Genes_NNS involved_VBN in_IN qac_NN and_CC beta-lactam_NN resistance_NN are_VBP gray_JJ and_CC black_JJ ,_, respectively_RB ._SENT qacA/B_NN encodes_VBZ QAC_NP resistance_NN ;_: qacR_NN encodes_VBZ a_DT putative_JJ repressor_NN of_IN qacA/B_NN ;_: sin_NN is_VBZ a_DT putative_JJ staphylococcal_JJ recombinase_NN gene_NN ;_: p271_NN encodes_VBZ a_DT potential_JJ ATP-binding_NP protein_NN ;_: p480_NN encodes_VBZ a_DT transposase_NN ;_: binR_NN and_CC binL_NN are_VBP resolvase-encoding_VBG genes_NNS ;_: blaZ_NP is_VBZ a_DT beta-lactamase_JJ structural_JJ gene_NN ;_: blaR_NN and_CC blaI_NNS are_VBP beta-lactamase_JJ regulatory_JJ genes_NNS ;_: IS257_JJ is_VBZ a_DT staphylococcal_JJ insertion_NN sequence_NN ._SENT Primers_NNS for_IN detection_NN of_IN specific_JJ PCR_NP products_NNS are_VBP indicated_VBN for_IN Fol33_NP ._SENT Vertical_JJ bars_NNS and_CC boxes_NNS downstream_JJ of_IN blaI_NP ,_, TIR_NP of_IN transposon_NP Tn552_NP and_CC a_DT resolution_NN site_NN (_( res_NNS )_) ,_, respectively_RB ._SENT TABLE_NN 1_CD |_SYM Screening_NN for_IN phenotypic_JJ susceptibility_NN to_TO BC_NP and_CC PEN_NP among_IN clinical_JJ staphylococci_NNS TABLE_NP 2_CD |_SYM Primers_NP used_VBN in_IN PCR_NP and_CC XL-PCR_NP amplification_NN Susceptibility_NN testing_NN ._SENT |_SYM The_DT 238_CD staphylococcus_NN isolates_NNS were_VBD screened_VBN for_IN QAC_NP (_( BC_NP )_) and_CC PEN_JJ resistance_NN ._SENT The_DT strains_NNS were_VBD categorized_VBN as_IN BC_NP resistant_JJ or_CC sensitive_JJ according_VBG to_TO the_DT BC_NP MICs_NP ._SENT One_CD hundred_CD eighteen_CD (_( 50_CD %_NN )_) isolates_NNS were_VBD considered_VBN BC_NP resistant_NN (_( BC_NP MICs_NP between_IN 3_CD and_CC 8_CD mug/ml_NN )_) ,_, and_CC 120_CD isolates_NNS were_VBD sensitive_JJ to_TO BC_NP (_( BC_NP MICs_NP <=_NN 2_CD mug/ml_NN )_) ._SENT Of_IN the_DT 238_CD staphylococcus_NN isolates_NNS ,_, 143_CD were_VBD found_VBN resistant_JJ to_TO PEN_NN ._SENT One_CD hundred_CD twenty-one_NN CNS_NP isolates_VBZ from_IN patients_NNS with_IN bloodstream_NN infections_NNS (_( n_NN =_SYM 60_CD )_) and_CC from_IN the_DT skin_NN of_IN children_NNS under_IN cancer_NN treatment_NN (_( n_NN =_SYM 61_CD )_) were_VBD analyzed_VBN for_IN correlation_NN between_IN BC_NP and_CC antibiotic_JJ resistance_NN ._SENT This_DT analysis_NN showed_VBD that_IN the_DT frequency_NN of_IN antibiotic_JJ resistance_NN was_VBD higher_JJR among_IN the_DT BC-resistant_JJ strains_NNS ._SENT As_IN an_DT example_NN ,_, a_DT large_JJ number_NN of_IN BC-resistant_JJ strains_NNS also_RB showed_VBD PEN_JJ resistance_NN ._SENT On_IN the_DT basis_NN of_IN Fisher_NP 's_POS exact_JJ test_NN ,_, these_DT distributions_NNS appear_VBP not_RB to_TO be_VB random_JJ (_( P_NN <=_NN 0.01_CD for_IN PEN_NP ,_, oxacillin_NN ,_, cephalothin_NN ,_, cefuroxime_NN ,_, imipenem_NP ,_, TMP_NP ,_, GEN_NP ,_, doxycycline_NN ,_, and_CC fusidic_JJ acid_NN )_) ._SENT None_NN of_IN the_DT isolates_NNS were_VBD resistant_JJ to_TO vancomycin_NP ,_, and_CC less_JJR than_IN 3_CD %_NN of_IN the_DT staphylococcus_NN isolates_NNS were_VBD resistant_JJ to_TO teicoplanin_NN and_CC rifampin_NN (_( results_NNS not_RB shown_VBN )_) ._SENT The_DT CNS_NNS from_IN HIV-positive_JJ outpatients_NNS and_CC S._NP aureus_NN from_IN patients_NNS with_IN bloodstream_NN infections_NNS were_VBD excluded_VBN from_IN the_DT analyses_NNS of_IN the_DT correlation_NN between_IN BC_NP and_CC antibiotic_JJ resistance_NN ,_, because_IN the_DT frequencies_NNS of_IN antibiotic_JJ resistance_NN among_IN these_DT isolates_NNS were_VBD relatively_RB low_JJ (_( data_NNS not_RB shown_VBN )_) ._SENT The_DT 118_CD BC-resistant_NP isolates_NNS were_VBD screened_VBN for_IN susceptibility_NN to_TO a_DT second_JJ disinfectant_NN ,_, CHX_NP ._SENT Twenty-eight_NN of_IN the_DT BC-resistant_NP isolates_NNS showed_VBD low_JJ resistance_NN to_TO CHX_NP (_( MIC_NP between_IN 1.5_CD and_CC 3.0_CD mug/ml_NN )_) ,_, whereas_IN 90_CD isolates_NNS were_VBD sensitive_JJ (_( MIC_JJ <=_1.0 =4_NN mug/ml_NN ,_, 11_CD and_CC 37_CD isolates_NNS were_VBD resistant_JJ to_TO disinfectant_NN Tego_NP 103G_NP and_CC dye_VB EBR_NP ,_, respectively_RB ._SENT Systematic_JJ cross-resistance_NN between_IN BC_NP and_CC EBR_NP and_CC no_DT systematic_JJ cross-resistance_NN between_IN BC_NP and_CC CHX_NP or_CC Tego_NP 103G_NP were_VBD found_VBN in_IN staphylococci_NNS ._SENT The_DT MIC_JJ tests_NNS and_CC disk_NN diffusion_NN test_NN revealed_VBD that_IN an_DT isolate_NN from_IN a_DT bloodstream_NN infection_NN ,_, Staphylococcus_NP epidermidis_NP Fol62_NP ,_, was_VBD resistant_JJ to_TO BC_NP (_( MIC_NP ,_, 5_CD mug/ml_NN )_) ,_, EBR_NP (_( MIC_NP ,_, 160_CD mug/ml_NN )_) ,_, Tego_NP 103G_NP (_( MIC_NP ,_, 10_CD mug/ml_NN )_) ,_, PEN_NP (_( MIC_NP ,_, 160_CD mug/ml_NN )_) ,_, AMP_NP (_( MIC_NP ,_, 160_CD mug/ml_NN )_) ,_, MET_NP (_( MIC_NP ,_, 50_CD mug/ml_NN )_) ,_, TET_NP (_( MIC_NP ,_, 70_CD mug/ml_NN )_) ,_, KAN_NP (_( MIC_NP ,_, 7_CD mug/ml_NN )_) ,_, ERY_NP (_( MIC_NP ,_, 80_CD mug/ml_NN )_) and_CC TMP_NP (_( MIC_NP ,_, 8_CD mug/ml_NN )_) ._SENT DNA_NN hybridizations_NNS ._SENT |_SYM Of_IN the_DT 118_CD BC-resistant_JJ isolates_NNS ,_, 78_CD isolates_NNS for_IN which_WDT the_DT BC_NP MICs_NP were_VBD high_JJ (_( MICs_NP between_IN 4_CD and_CC 8_CD mug/ml_NN )_) were_VBD selected_VBN for_IN DNA_NP hybridization_NN studies_NNS ._SENT Plasmid_NP DNA_NP from_IN these_DT isolates_NNS was_VBD screened_VBN for_IN the_DT presence_NN of_IN known_VBN gram-positive_JJ bacterium_NN qac_NN genes_NNS mediating_VBG resistance_NN (_( qacA/B_NP ,_, qacC_NP ,_, qacG_NN ,_, and_CC qacH_NN )_) ,_, beta-lactamase_NN genes_NNS (_( blaZ_NP ,_, blaI_NP ,_, and_CC blaR_NN )_) ,_, other_JJ antibiotic_JJ resistance_NN genes_NNS (_( ermC_NP ,_, cat_NN ,_, dfrA_NP ,_, and_CC tetK_NN )_) ,_, and_CC staphylococcal_JJ insertion_NN sequences_NNS IS257_JJ and_CC IS256_NP by_IN Southern_NP blotting_VBG and_CC hybridization_NN ._SENT Sixty-seven_JJ of_IN the_DT BC-resistant_NP isolates_NNS harbored_VBD either_DT qacA/B_NN or_CC qacC_NN on_IN plasmid_NP DNA_NP ,_, and_CC the_DT qacA/B_NN gene_NN was_VBD detected_VBN by_IN PCR_NP (_( total_JJ DNA_NN was_VBD the_DT template_NN )_) in_IN the_DT remaining_VBG 11_CD isolates_NNS ._SENT Neither_CC the_DT qacG_NN nor_CC the_DT qacH_NN gene_NN was_VBD detected_VBN among_IN the_DT isolates_NNS ._SENT Plasmids_NNS from_IN 43_CD strains_NNS also_RB hybridized_VBN with_IN beta-lactamase_NN probes_NNS ._SENT In_IN 19_CD of_IN these_DT strains_NNS ,_, qac_NN and_CC blaZ_NN ,_, blaI_NP ,_, and_CC blaR_NN resided_VBN on_IN the_DT same_JJ plasmid_NN ._SENT Only_RB S._NP epidermidis_NP Fol62_NP plasmid_NP pMS62_NN (_( 32_CD kb_NN )_) hybridized_VBN with_IN other_JJ antibiotic_JJ resistance_NN gene_NN probes_NNS tested_VBN (_( tetK_NN ,_, IS257_JJ ,_, ermC_NN ,_, aacA-aphD_NNS ,_, and_CC dfrA_NN )_) in_IN addition_NN to_TO qacA/B_NN ,_, blaZ_NP ,_, blaI_NP ,_, and_CC blaR_NN ._SENT tetK_NN and_CC a_DT copy_NN of_IN IS257_JJ were_VBD localized_VBN adjacent_JJ to_TO blaZ_NN ._SENT However_RB ,_, no_DT XL-PCR_NP products_NNS were_VBD obtained_VBN when_WRB DNA_NP stretches_VBZ between_IN tetK_NN or_CC qacA/B_NN and_CC antibiotic_JJ resistance_NN gene_NN ermC_NN ,_, aacA-aphD_NNS ,_, or_CC dfrA_NN were_VBD amplified_VBN ._SENT The_DT determinant_NN for_IN MET_NP resistance_NN (_( mecA_NN )_) in_IN S._NP epidermidis_NP Fol62_NP was_VBD chromosomally_RB encoded_VBN ._SENT Genetic_JJ organizations_NNS of_IN the_DT qac_NN and_CC beta-lactamase_NN genes_NNS ._SENT |_SYM From_IN the_DT 19_CD staphylococcus_NN isolates_VBZ harboring_VBG disinfectant_NN qac_NN and_CC beta-lactamase_NN genes_NNS on_IN the_DT same_JJ plasmids_NNS ,_, we_PP selected_VBD six_CD isolates_NNS for_IN a_DT study_NN of_IN gene_NN organization_NN ,_, isolates_VBZ Fol24_NP (_( pMS24_NP ,_, 30_CD kb_NN )_) ,_, Fol33_NP (_( pMS33_NP ,_, 35_CD kb_NN )_) ,_, Fol62_NP (_( pMS62_NP ,_, 32_CD kb_NN )_) ,_, Fol89_NP (_( pMS89_NP ,_, 40_CD kb_NN )_) ,_, Fol90_NP (_( pMS90_NP ,_, 35_CD kb_NN )_) ,_, and_CC Fol100_NP (_( pMS100_NP ,_, 40_CD kb_NN )_) (_( plasmid_NN designations_NNS and_CC approximate_JJ sizes_NNS are_VBP in_IN parentheses_NNS )_) ._SENT These_DT isolates_NNS were_VBD all_RB identified_VBN as_IN S._NP epidermidis_NNS ._SENT Isolates_VBZ Fol24_NP ,_, Fol33_NP ,_, and_CC Fol62_NP were_VBD from_IN patients_NNS having_VBG bloodstream_NN infections_NNS ,_, and_CC isolates_VBZ Fol89_NP ,_, Fol90_NP ,_, and_CC Fol100_NP were_VBD from_IN the_DT skin_NN of_IN children_NNS treated_VBN for_IN cancer_NN ._SENT Results_NNS obtained_VBN by_IN XL-PCR_NP and_CC DNA_NP sequencing_NP indicated_VBD different_JJ structural_JJ arrangements_NNS of_IN the_DT beta-lactamase_NN genes_NNS and_CC the_DT disinfectant_NN resistance_NN qacA/B_NN genes_NNS ,_, including_VBG variable_JJ intergenic_JJ distances_NNS and_CC different_JJ transcriptional_JJ orientations_NNS of_IN genes_NNS located_VBN on_IN the_DT same_JJ plasmids_NNS ._SENT Staphylococcal_JJ plasmids_NNS pMS24_NN ,_, pMS33_NN ,_, and_CC pMS89_NN harbor_VBP a_DT complete_JJ copy_NN of_IN transposon_NP Tn552_NP ,_, comprising_VBG p271_JJ ,_, p480_JJ ,_, and_CC binL_NN ,_, encoding_VBG a_DT potential_JJ ATP-binding_NP protein_NN ,_, a_DT transposase_NN ,_, and_CC a_DT resolvase_NN ,_, respectively_RB ,_, in_IN addition_NN to_TO the_DT beta-lactamase_JJ structural_JJ gene_NN (_( blaZ_NP )_) and_CC regulatory_JJ genes_NNS (_( blaR_NN and_CC blaI_NNS )_) ._SENT Staphylococcal_JJ insertion_NN sequence_NN IS257_JJ was_VBD found_VBN downstream_RB of_IN the_DT blaZ_NN gene_NN in_IN these_DT plasmids_NNS ._SENT There_EX were_VBD sequences_NNS homologous_JJ to_TO the_DT right_JJ TIR_NP (_( TIRR_NP )_) of_IN Tn552_NP downstream_JJ of_IN blaZ_NP ,_, a_DT resL_NN site_NN between_IN blaI_NN and_CC binL_NN ,_, and_CC a_DT sequence_NN homologous_JJ to_TO TIRL_NP of_IN Tn552_NP downstream_JJ of_IN p271_NN ._SENT Isolates_VBZ Fol24_NP ,_, Fol33_NP ,_, and_CC Fol89_NP harbored_VBD the_DT qacA/B_NN gene_NN together_RB with_IN their_PP$ regulatory_JJ gene_NN ,_, qacR_NN ,_, downstream_RB of_IN the_DT p271_JJ gene_NN ._SENT However_RB ,_, the_DT region_NN between_IN p271_NN and_CC qacR_NN was_VBD different_JJ for_IN different_JJ isolates_NNS ._SENT Fol24_NP and_CC Fol89_NP had_VBD very_RB similar_JJ regions_NNS and_CC contained_VBD the_DT sin_NN gene_NN ,_, encoding_VBG a_DT putative_JJ recombinase_NN ,_, while_IN the_DT sin_NN gene_NN was_VBD absent_JJ in_IN Fol33_NP ._SENT Plasmid_NP pMS62_NP harbored_VBD the_DT incomplete_JJ right_JJ half_NN of_IN the_DT transposon_NN Tn552-like_JJ bla_NN gene_NN module_NN upstream_RB of_IN the_DT binR_NN and_CC sin_NN genes_NNS ._SENT Also_RB in_IN pMS62_JJ ,_, IS257_JJ was_VBD found_VBN downstream_JJ and_CC adjacent_JJ to_TO blaZ_NN ._SENT The_DT tetK_NN gene_NN ,_, encoding_VBG TET_NP resistance_NN ,_, was_VBD located_VBN approximately_RB 2.4_CD kb_NN further_RBR downstream_JJ ._SENT In_IN Fol90_NP and_CC Fol100_NP the_DT orientation_NN of_IN beta-lactamase_JJ gene_NN clusters_NNS was_VBD inverted_VBN relative_JJ to_TO the_DT qacA/B_NN gene_NN cluster_NN ,_, so_RB that_DT qacR_NN was_VBD situated_VBN downstream_RB of_IN blaZ_NP ._SENT In_IN pMS90_NN the_DT intergenic_JJ sequence_NN between_IN blaZ_NP and_CC qacR_NP contained_VBD only_RB the_DT inverted_JJ repeat_NN of_IN Tn552_NP ,_, while_IN in_IN pMS100_NN this_DT region_NN contained_VBD a_DT sin_NN and_CC an_DT additional_JJ noncoding_NN 743_CD bp_NN of_IN DNA_NP ._SENT DNA_NP hybridization_NN and_CC PCR_NP confirmed_VBD the_DT presence_NN of_IN staphylococcal_JJ insertion_NN sequence_NN IS257_JJ on_IN pMS90_NN and_CC pMS100_NN ._SENT When_WRB the_DT DNA_NN stretches_VBZ between_IN the_DT beta-lactamase_NN genes_NNS and_CC disinfectant_NN resistance_NN gene_NN qacA/B_NN were_VBD amplified_VBN by_IN using_VBG primer_JJR combinations_NNS qac_JJ IV_NP and_CC blaI_NP R2_NP and_CC qac_NP IV_NP and_CC blaZ_NP 2F_NP ,_, both_DT primer_NN sets_NNS gave_VBD rise_NN to_TO PCR_NP products_NNS in_IN strains_NNS Fol33_NP and_CC Fol89_NP ._SENT DNA_NP sequencing_NP of_IN the_DT PCR_NP products_NNS of_IN qac_NP IV_NP and_CC blaZ_NP 2F_NP revealed_VBD that_IN the_DT blaZ_NN and_CC the_DT qacR_NN genes_NNS were_VBD located_VBN very_RB close_JJ to_TO each_DT other_JJ ,_, with_IN the_DT TIR_NP of_IN Tn552_NP between_IN the_DT genes_NNS ._SENT These_DT strains_NNS apparently_RB harbored_VBD the_DT gene_NN clusters_NNS in_IN two_CD orientations_NNS ._SENT The_DT nucleotide_NN and_CC deduced_VBN amino_NN acid_NN sequences_NNS derived_VBN from_IN complete_JJ and_CC incomplete_JJ (_( Tn552-like_JJ bla_NN gene_NN module_NN )_) Tn552_JJ transposons_NNS of_IN plasmids_NNS pMS24_JJ ,_, pMS33_JJ ,_, pMS89_JJ ,_, and_CC pMS62_NN were_VBD identical_JJ to_TO those_DT derived_VBN from_IN staphylococcal_JJ beta-lactamase_NN transposon_NP Tn552_NP ._SENT The_DT deduced_VBN amino_NN acid_NN sequences_NNS derived_VBN from_IN qacR_NN of_IN plasmids_NNS pMS24_JJ ,_, pMS33_JJ ,_, pMS62_JJ ,_, pMS89_JJ ,_, pMS90_JJ ,_, and_CC pMS100_NN and_CC qacA/B_NN of_IN pMS33_NN were_VBD similar_JJ to_TO those_DT derived_VBN from_IN pST6_NN ,_, pSK156_NN ,_, and_CC pSK23_NN ._SENT Similarly_RB ,_, the_DT deduced_VBN amino_NN acid_NN sequences_NNS derived_VBN from_IN the_DT resolvase_NN gene_NN (_( binR_NN )_) of_IN pMS62_NN was_VBD 100_CD %_NN identical_JJ to_TO that_DT derived_VBN from_IN pST6_NN (_( AY028779_NP )_) and_CC 99_CD %_NN similar_JJ to_TO that_DT derived_VBN from_IN pNVH96_NN (_( AJ302698_NP )_) ._SENT The_DT recombinase_NN genes_NNS (_( sin_NN )_) of_IN pMS62_NN and_CC pMS89_NN were_VBD 100_CD %_NN identical_JJ and_CC 99_CD %_NN similar_JJ to_TO those_DT of_IN pST6_NP and_CC pNVH97A_NP (_( AJ400722_NP )_) ,_, respectively_RB ._SENT The_DT sin_NN gene_NN of_IN Fol100_NP is_VBZ 100_CD %_NN identical_JJ to_TO that_DT of_IN S._NP epidermidis_NNS strain_VBP SR1_NP and_CC 90_CD %_NN similar_JJ to_TO the_DT sin_NN genes_NNS of_IN Fol62_NP and_CC Fol89_NP ._SENT FIG._NN 1_CD ._SENT |_SYM Percentages_NP of_IN antibiotic-resistant_NP CNS_NP isolates_VBZ from_IN patients_NNS with_IN bloodstream_NN infections_NNS (_( n_NN =_SYM 60_CD )_) and_CC from_IN the_DT skin_NN of_IN children_NNS under_IN cancer_NN treatment_NN (_( n_NN =_SYM 61_CD )_) among_IN BC-resistant_NP and_CC BC-sensitive_NP isolates_VBZ ._SENT Percentages_NNS of_IN antibiotic-resistant_JJ CNS_NP isolates_NNS from_IN patients_NNS with_IN bloodstream_NN infections_NNS (_( n_NN =_SYM 60_CD )_) and_CC from_IN the_DT skin_NN of_IN children_NNS under_IN cancer_NN treatment_NN (_( n_NN =_SYM 61_CD )_) among_IN BC-resistant_NP and_CC BC-sensitive_NP isolates_VBZ ._SENT Antibiotics_NNS used_VBN are_VBP PEN_JJ ,_, oxacillin_NN (_( OXA_NP )_) ,_, cephalothin_NP (_( CEP_NP )_) ,_, cefuroxime_NN (_( CEF_NP )_) ,_, imipenem_NP (_( IMI_NP )_) ,_, cotrimoxazole_NN (_( COT_NP )_) ,_, ERY_NP ,_, clindamycin_NN (_( CLI_NP )_) ,_, GEN_NP ,_, ciprofloxacin_NP (_( CIP_NP )_) ,_, doxycycline_NP (_( DOX_NP )_) ,_, chloramphenicol_NN (_( CHL_NP )_) ,_, and_CC fusidic_JJ acid_NN (_( FUS_NP )_) ._SENT Susceptibility_NN to_TO CEF_NP ,_, IMI_NP ,_, and_CC CHL_NP was_VBD tested_VBN only_RB among_IN CNS_NP isolates_VBZ from_IN patients_NNS with_IN bloodstream_NN infections_NNS (_( asterisks_NNS )_) ._SENT TABLE_NN 3_CD |_SYM BC-resistant_JJ isolates_NNS were_VBD screened_VBN for_IN susceptibility_NN to_TO disinfectants_NNS and_CC dye_NN by_IN a_DT microdilution_NN method_NN TABLE_NP 4_CD |_SYM Screening_NN for_IN the_DT presence_NN of_IN disinfectant_NN and_CC various_JJ antibiotic_JJ resistance_NN genes_NNS on_IN plasmid_NP DNA_NP among_IN BC-resistant_NP staphylococci_NNS Little_NP is_VBZ known_VBN about_IN the_DT occurrence_NN and_CC possible_JJ genetic_JJ linkage_NN of_IN qac_NN and_CC antibiotic_JJ resistance_NN in_IN staphylococci_NNS ._SENT Of_IN the_DT 238_CD human_JJ clinical_JJ isolates_NNS from_IN Norway_NP investigated_VBD in_IN this_DT study_NN ,_, 50_CD %_NN were_VBD phenotypically_RB resistant_JJ to_TO BC_NP ._SENT Plasmid-borne_JJ qacA/B_NN and_CC qacC_NN genes_NNS were_VBD detected_VBN in_IN 83_CD and_CC 3_CD %_NN of_IN the_DT BC-resistant_JJ staphylococcus_NN isolates_NNS ,_, respectively_RB ._SENT The_DT qacA/B_NN genes_NNS were_VBD also_RB detected_VBN in_IN the_DT remaining_VBG BC-resistant_NN isolates_NNS ,_, indicating_VBG that_IN the_DT genes_NNS were_VBD either_RB chromosomally_RB located_VBN or_CC present_JJ on_IN large_JJ plasmids_NNS not_RB obtained_VBN by_IN the_DT plasmid_NP isolation_NN procedure_NN ._SENT Previous_JJ investigators_NNS have_VBP reported_VBN a_DT similar_JJ distribution_NN of_IN these_DT three_CD qac_NN resistance_NN genes_NNS in_IN clinical_JJ S._NP aureus_NN and_CC CNS_NNS although_IN additional_JJ staphylococcal_JJ disinfectant_NN resistance_NN genes_NNS also_RB have_VBP been_VBN indicated_VBN ._SENT A_DT lower_JJR prevalence_NN of_IN QAC_NP resistance_NN (_( 13_CD %_NN )_) was_VBD reported_VBN for_IN staphylococci_NNS from_IN food_NN and_CC the_DT food-processing_JJ industry_NN ._SENT Here_RB ,_, both_DT qacA/B_NN and_CC qacC_NN as_RB well_RB as_IN qacG_NN and_CC qacH_NN were_VBD reported_VBN ,_, with_IN qacC_NN as_IN the_DT most_RBS prevalent_JJ determinant_NN ._SENT Overall_RB ,_, it_PP seems_VBZ likely_RB that_IN the_DT presence_NN ,_, maintenance_NN ,_, and_CC widespread_JJ dissemination_NN of_IN multidrug_NN efflux_NN qac_NN genes_NNS in_IN staphylococci_NNS are_VBP a_DT consequence_NN of_IN the_DT selective_JJ pressure_NN exerted_VBN by_IN the_DT use_NN of_IN antiseptics_NNS and_CC disinfectants_NNS ._SENT Many_JJ of_IN the_DT staphylococci_NNS included_VBD in_IN this_DT study_NN were_VBD resistant_JJ to_TO different_JJ antibiotics_NNS ,_, but_CC in_IN general_NN the_DT antibiotic_JJ resistance_NN was_VBD considered_VBN low_RB compared_VBN to_TO findings_NNS in_IN other_JJ studies_NNS ._SENT Interestingly_RB ,_, we_PP observed_VBD that_IN staphylococci_NNS resistant_JJ to_TO BC_NP were_VBD generally_RB more_RBR often_RB resistant_JJ to_TO antibiotics_NNS than_IN BC-sensitive_JJ isolates_NNS ._SENT The_DT results_NNS are_VBP compatible_JJ with_IN selective_JJ advantages_NNS of_IN isolates_NNS carrying_VBG both_DT disinfectant_NN and_CC antibiotic_JJ resistance_NN genes_NNS ,_, and_CC the_DT data_NNS indicate_VBP that_IN the_DT presence_NN of_IN qac_JJ genes_NNS in_IN staphylococci_NNS results_NNS in_IN selection_NN of_IN antibiotic-resistant_JJ bacteria_NNS ._SENT Russell_NP also_RB speculated_VBD that_IN disinfectant_NN resistance_NN might_MD contribute_VB to_TO antibiotic_JJ resistance_NN by_IN coresistance_NN or_CC cross-resistance_NN mechanisms_NNS or_CC coselection_NN ._SENT This_DT study_NN detected_VBD a_DT systematic_JJ genetic_JJ linkage_NN between_IN resistance_NN to_TO BC_NP and_CC PEN_NP although_IN less_JJR than_IN one-half_NN of_IN the_DT plasmid-encoded_JJ beta-lactamase_NN resistance_NN was_VBD linked_VBN to_TO disinfectant_NN resistance_NN genes_NNS (_( 19_CD of_IN 43_CD isolates_NNS )_) ._SENT Previous_JJ investigators_NNS have_VBP also_RB reported_VBN genetic_JJ linkage_NN between_IN disinfectant_NN (_( qac_NN )_) and_CC antibiotic_JJ resistance_NN genes_NNS (_( blaZ_NP ,_, aacA-aphD_NN ,_, dfrA_NP ,_, and_CC ble_NNS )_) on_IN the_DT same_JJ staphylococcal_JJ plasmids_NNS from_IN clinics_NNS ,_, food_NN environments_NNS ,_, and_CC an_DT animal_JJ clinic_NN (_( I.-L_NP ._SENT Anthonisen_NP et_FW al._FW ,_, unpublished_JJ data_NNS )_) ._SENT To_TO our_PP$ knowledge_NN ,_, this_DT paper_NN is_VBZ the_DT first_JJ report_NN of_IN closely_RB linked_VBN qac_NN ,_, beta-lactamase_NN ,_, and_CC tetK_NN genes_NNS on_IN a_DT multiresistance_NN plasmid_NN (_( pMS62_NN )_) ._SENT Plasmid_NP pMS62_NP also_RB harbored_VBD ermC_NN ,_, dfrA_NP ,_, and_CC aacA-aphD_NNS ,_, encoding_VBG resistance_NN to_TO ERY_NP ,_, TMP_NP ,_, and_CC GEN-KAN-tobramycin_NP ,_, respectively_RB ._SENT No_DT genetic_JJ linkage_NN between_IN qac_NN and_CC these_DT or_CC other_JJ antibiotic_JJ resistance_NN genes_NNS tested_VBN was_VBD detected_VBN ._SENT The_DT observed_JJ cross-resistance_NN between_IN BC_NP and_CC EBR_NP is_VBZ compatible_JJ with_IN the_DT ability_NN of_IN all_DT known_VBN qac_NN resistance_NN determinants_NNS to_TO cause_VB the_DT efflux_NN of_IN structurally_RB similar_JJ ,_, monovalent_JJ cationic_JJ agents_NNS ._SENT A_DT low-level_JJ CHX_NP resistance_NN phenotype_NN probably_RB reflects_VBZ isolates_NNS expressing_VBG qacA_NN ,_, which_WDT also_RB encodes_VBZ resistance_NN to_TO divalent_JJ cations_NNS ,_, while_IN resistance_NN to_TO the_DT amphoteric_JJ disinfectant_NN Tego_NP 103G_NP is_VBZ probably_RB due_JJ to_TO other_JJ mechanisms_NNS ._SENT The_DT genetic_JJ organizations_NNS between_IN qac_NN and_CC beta-lactamase_NN genes_NNS in_IN six_CD plasmids_NNS (_( pMS24_NP ,_, pMS33_NP ,_, pMS62_NN ,_, pMS89_NN ,_, pMS90_NN ,_, and_CC pMS100_NN )_) were_VBD studied_VBN ._SENT The_DT plasmids_NNS originated_VBN from_IN isolates_NNS from_IN different_JJ sources_NNS and_CC distant_JJ geographic_JJ areas_NNS ,_, and_CC their_PP$ genetic_JJ organizations_NNS showed_VBD similarities_NNS with_IN those_DT of_IN other_JJ known_VBN staphylococcal_JJ plasmids_NNS ,_, e.g._FW ,_, pSK1_JJ ,_, pSK4_JJ ,_, pSK23_JJ ,_, pSK57_JJ ,_, pSK108_JJ ,_, pSK156_NN ,_, pNVH97A_NP ,_, pNVH96_NP ,_, pI258_NN ,_, and_CC pI9789_NN ._SENT Our_PP$ results_NNS generally_RB confirmed_VBD previous_JJ findings_NNS that_IN beta-lactamase-related_JJ transposons_NNS Tn552_NP and_CC Tn4002_NP preferentially_RB insert_VB within_IN TIRL_NP located_VBN upstream_RB of_IN the_DT sin_NN gene_NN ._SENT Insertion_NN of_IN Tn552-like_JJ transposons_NNS adjacent_JJ to_TO qac_NN genes_NNS also_RB occurs_VBZ frequently_RB ,_, as_IN observed_VBN in_IN isolates_NNS Fol133_NP ,_, Fol89_NP ,_, Fol90_NP ,_, and_CC Fol100_NP (_( this_DT study_NN )_) ._SENT Overall_RB ,_, this_DT suggests_VBZ that_IN genetic_JJ organizations_NNS containing_VBG IS257_JJ ,_, Tn552_NP ,_, binR_NN ,_, and_CC sin_NN and/or_CC qacR_NN and_CC qacA/B_NN are_VBP widely_RB distributed_VBN among_IN staphylococci_NNS from_IN clinical_JJ as_RB well_RB as_IN food_NN environments_NNS ._SENT Various_JJ rearrangements_NNS and_CC DNA_NN inversions_NNS generating_VBG two_CD alternative_JJ staphylococcal_JJ beta-lactamase_NN transposons_NNS have_VBP been_VBN reported_VBN ._SENT We_PP also_RB found_VBD the_DT presence_NN of_IN additional_JJ organizations_NNS of_IN Tn552_NP and_CC qacA/B_NN within_IN the_DT genomes_NNS of_IN strains_NNS Fol33_NP and_CC Fol89_NP ._SENT On_IN pMS62_NN ,_, the_DT resolvase-_NN and_CC recombinase-encoding_NN genes_NNS (_( binR_NN and_CC sin_NN ,_, respectively_RB )_) were_VBD present_JJ between_IN qac_NN and_CC the_DT incomplete_JJ Tn552-like_JJ bla_NN gene_NN module_NN as_IN in_IN S._NP aureus_NN plasmid_NN pS1_NN ._SENT The_DT truncated_JJ Tn552_NN observed_VBD in_IN pMS62_NN has_VBZ probably_RB lost_VBN its_PP$ ability_NN to_TO transpose_VB ,_, as_IN the_DT transposase_NN gene_NN (_( p480_NN )_) was_VBD not_RB detected_VBN ._SENT Staphylococcal_JJ insertion_NN sequence_NN IS257_JJ plays_VBZ a_DT central_JJ role_NN in_IN cointegration_NN events_NNS ._SENT Large_JJ ,_, conjugative_JJ plasmid_NP pSK41_NN has_VBZ integrated_VBN several_JJ small_JJ plasmids_NNS ,_, where_WRB all_PDT the_DT cointegrated_JJ plasmids_NNS are_VBP all_RB flanked_VBN by_IN copies_NNS of_IN IS257_JJ ._SENT IS257_JJ has_VBZ been_VBN found_VBN closely_RB associated_VBN with_IN Tn552_NP ,_, qacB_NN (_( pSK156_NN )_) ,_, qacA_NP (_( AJ400722_NP )_) ,_, and_CC qacC_NN as_RB well_RB as_IN antibiotic_JJ resistance_NN determinants_NNS ,_, e.g._FW ,_, dfrA_NP ,_, tetK_NN ,_, and_CC aacA-aphD_NNS ._SENT The_DT presence_NN of_IN IS257_JJ downstream_JJ of_IN blaZ_NN on_IN pMS33_NN ,_, pMS24_NN ,_, pMS62_NN ,_, and_CC pMS89_NN ,_, and_CC also_RB detected_VBN on_IN pMS90_NN and_CC pMS100_NN ,_, indicates_VBZ that_IN IS257_JJ integration_NN events_NNS were_VBD involved_VBN in_IN the_DT formation_NN of_IN the_DT structures_NNS of_IN these_DT plasmids_NNS ._SENT The_DT presence_NN of_IN insertion_NN sequences_NNS IS257_JJ and_CC IS256_JJ on_IN some_DT of_IN the_DT plasmids_NNS harboring_VBG either_DT qacA/B_NN or_CC beta-lactamase_NN genes_NNS suggests_VBZ that_IN these_DT plasmids_NNS may_MD act_VB as_IN a_DT source_NN for_IN formation_NN of_IN new_JJ multiresistance_NN plasmids_NNS ._SENT Taken_VBN together_RB the_DT above_JJ observations_NNS indicate_VBP that_IN a_DT number_NN of_IN different_JJ recombination_NN events_NNS have_VBP occurred_VBN to_TO yield_VB the_DT various_JJ genetic_JJ organizations_NNS ._SENT To_TO investigate_VB the_DT stability_NN of_IN the_DT plasmids_NNS harboring_VBG disinfectant_NN and_CC antibiotic_JJ resistance_NN genes_NNS ,_, we_PP tried_VBD to_TO cure_VB the_DT isolates_NNS for_IN plasmids_NNS ._SENT None_NN of_IN the_DT strains_NNS were_VBD cured_VBN for_IN the_DT resistance_NN plasmids_NNS ._SENT This_DT indicated_VBD that_IN plasmids_NNS are_VBP stably_RB maintained_VBN in_IN these_DT strains_NNS ._SENT 